How effective is famotidine 20mg twice daily compared to 40mg twice daily for treating erosive reflux esophagitis. What are the optimal dosing recommendations for famotidine in reflux esophagitis patients. How does famotidine dosage impact symptom relief and esophageal healing in reflux disease.

Famotidine Efficacy in Treating Reflux Esophagitis

Famotidine is a medication commonly used to treat conditions related to excess stomach acid, including gastroesophageal reflux disease (GERD) and erosive esophagitis. A key question for both patients and healthcare providers is determining the optimal dosage for effective treatment. This article examines a clinical study comparing two different dosing regimens of famotidine for treating erosive or ulcerative reflux esophagitis.

Study Overview

The study was a double-blind, randomized multicenter trial involving 474 symptomatic patients with erosive ulcerative reflux esophagitis. Participants were divided into two groups:

• 238 patients received famotidine 20 mg twice daily
• 236 patients received famotidine 40 mg twice daily

Both groups took the medication at breakfast and dinner time. The study aimed to evaluate the efficacy of these two dosing regimens in relieving symptoms and promoting esophageal healing.

Symptom Relief and Endoscopic Healing Results

How did the two dosing regimens compare in terms of symptom relief? The study found that both groups experienced significant symptom relief after 6 and 12 weeks of treatment. Interestingly, there was no significant difference in symptom relief between the 20 mg and 40 mg twice daily groups.

However, when it came to endoscopic healing, the results showed a clear advantage for the higher dose:

• At 6 weeks: 58% healing rate for 40 mg group vs. 43% for 20 mg group (P < 0.05)
• At 12 weeks: 76% healing rate for 40 mg group vs. 67% for 20 mg group (P < 0.05)

These findings indicate that while both doses effectively alleviated symptoms, the 40 mg twice daily dose was significantly more effective in promoting esophageal healing.

Impact of Esophagitis Severity on Treatment Efficacy

Does the severity of esophagitis affect the relative efficacy of the two dosing regimens? The study revealed that the differences in efficacy between the two doses became more pronounced as the severity of esophagitis increased.

When analyzed by grade of esophagitis at the start of treatment, the 40 mg twice daily dose showed significantly better healing rates:

• Grade II esophagitis: Better healing at 6 weeks
• Grades III and IV esophagitis: Better healing at 12 weeks
• Grade IV esophagitis: Better healing at 24 weeks

This suggests that patients with more severe esophagitis may benefit more from the higher dose of famotidine.

Extended Treatment and Healing Rates

Is extending treatment beyond 12 weeks beneficial for patients who haven’t fully healed? The study examined this question by continuing treatment for an additional 12 weeks (total 24 weeks) with 40 mg of famotidine twice daily for patients who had not achieved complete healing after the initial 12-week period.

Surprisingly, this extended treatment did not result in:

• Further significant symptom relief
• Significantly better overall healing rates

This finding suggests that for most patients, the majority of healing occurs within the first 12 weeks of treatment, and extending treatment may not provide substantial additional benefits.

Implications for Treatment Recommendations

What do these results mean for healthcare providers and patients considering famotidine treatment for erosive reflux esophagitis? The study provides several important insights:

1. Both 20 mg and 40 mg twice daily doses of famotidine are effective in relieving symptoms of reflux esophagitis.
2. The 40 mg twice daily dose is more effective in promoting esophageal healing, particularly in cases of more severe esophagitis.
3. The higher dose achieves faster healing rates compared to the lower dose.
4. Extended treatment beyond 12 weeks may not provide significant additional benefits for most patients.

Based on these findings, healthcare providers may consider prescribing the 40 mg twice daily dose, especially for patients with more severe grades of esophagitis or those who require faster healing.

Considerations for Individualized Treatment

While the study provides valuable insights into the efficacy of different famotidine dosing regimens, it’s important to remember that treatment should be tailored to individual patient needs. Factors to consider when determining the appropriate famotidine dose may include:

• Severity of esophagitis
• Patient’s response to previous treatments
• Presence of other medical conditions
• Potential drug interactions
• Patient preferences and lifestyle factors

Healthcare providers should weigh these factors alongside the study results when making treatment decisions.

Safety and Tolerability of Famotidine

Are there significant differences in safety or tolerability between the two dosing regimens? While the study focused primarily on efficacy, it’s worth noting that famotidine is generally well-tolerated at both the 20 mg and 40 mg twice daily doses.

Common side effects of famotidine may include:

• Headache
• Dizziness
• Constipation or diarrhea
• Nausea or vomiting

Patients should be advised to report any persistent or severe side effects to their healthcare provider. The choice between the two doses should balance the potential for increased efficacy with any increased risk of side effects.

Future Research Directions

While this study provides valuable insights into famotidine dosing for erosive reflux esophagitis, several questions remain that could benefit from further research:

• Long-term efficacy and safety of the 40 mg twice daily dose beyond 24 weeks
• Comparison of famotidine with other acid-suppressing medications for reflux esophagitis
• Identification of patient subgroups who may benefit most from the higher dose
• Potential for step-down therapy after initial healing with the higher dose
• Impact of famotidine treatment on quality of life measures

Ongoing research in these areas will help to further refine treatment strategies for patients with erosive reflux esophagitis.

In conclusion, this study provides strong evidence supporting the use of famotidine 40 mg twice daily as a more effective treatment option for patients with erosive or ulcerative reflux esophagitis, particularly those with more severe disease. However, treatment decisions should always be made on an individual basis, considering the unique needs and circumstances of each patient. As our understanding of GERD and related conditions continues to evolve, so too will our approaches to treatment, with the ultimate goal of providing optimal care and improved quality of life for patients suffering from these conditions.

Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis

Save citation to file

Format:

Summary (text)PubMedPMIDAbstract (text)CSV

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection:

Name must be less than 100 characters

Choose a collection:

Unable to load your collection due to an error
Please try again

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error
Please try again

Your saved search

Name of saved search:

Search terms:

Test search terms

Email:

(change)

Which day?

The first SundayThe first MondayThe first TuesdayThe first WednesdayThe first ThursdayThe first FridayThe first SaturdayThe first dayThe first weekday

Which day?

SundayMondayTuesdayWednesdayThursdayFridaySaturday

Report format:

SummarySummary (text)AbstractAbstract (text)PubMed

Send at most:

1 item5 items10 items20 items50 items100 items200 items

Send even when there aren’t any new results

Optional text in email:

Create a file for external citation management software

Clinical Trial

. 1993 Dec;38(12):2287-93.

doi: 10.1007/BF01299910.

I C Wesdorp 
¹
, W Dekker, H P Festen

Affiliations

Affiliation

• ¹ Department of Gastroenterology, Andreas Ziekenhuis, Amsterdam, The Netherlands.

• PMID:

  8261835

• DOI:

  10.1007/BF01299910

Clinical Trial

I C Wesdorp et al.

Dig Dis Sci.

1993 Dec.

. 1993 Dec;38(12):2287-93.

doi: 10.1007/BF01299910.

Authors

I C Wesdorp 
¹
, W Dekker, H P Festen

Affiliation

• ¹ Department of Gastroenterology, Andreas Ziekenhuis, Amsterdam, The Netherlands.

• PMID:

  8261835

• DOI:

  10.1007/BF01299910

Abstract

Two different doses of famotidine (20 mg twice a day versus 40 mg twice a day) were evaluated in a double-blind, randomized multicenter study in 474 symptomatic patients with erosive ulcerative reflux esophagitis. A total of 238 patients were treated with famotidine 20 mg and 236 patients with 40 mg at breakfast and dinner-time. Relief of symptoms was significant in all patients after six and 12 weeks and not different in both treatment groups. Overall endoscopic healing was significantly better in the famotidine 40 mg twice a day group compared with 20 mg twice a day at week 6 (58% versus 43%; P < 0.05) and at week 12 (76% versus 67%; P < 0. 05). Extending treatment to 24 weeks with 40 mg of famotidine twice a day in those patients not healed after 12 weeks did not result in further symptom relief or in significantly better overall healing. The differences in efficacy of these two doses were more pronounced with increasing severity of esophagitis. Analyzed by grade of esophagitis at entrance, healing was significantly better with famotidine 40 mg twice a day at week 6 for grade II, at week 12 for grades III and IV, and at week 24 for grade IV esophagitis. The results show that in the treatment of erosive/ulcerative reflux patients famotidine 40 mg twice a day is more effective and achieves faster healing than famotidine 20 mg twice a day.

Similar articles

• Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group.

  Simon TJ, Berlin RG, Tipping R, Gilde L.

  Simon TJ, et al.
  Scand J Gastroenterol. 1993 May;28(5):375-80. doi: 10.3109/00365529309098235.
  Scand J Gastroenterol. 1993.

  PMID: 8511496

  Clinical Trial.

• Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial.

  Kim EH, Lee YC, Chang YW, Park JJ, Chun HJ, Jung HY, Kim HS, Jeong HY, Seol SY, Han SW, Choi MG, Park SH, Lee OJ, Jung JT, Lee DH, Jung HC, Lee ST, Kim JG, Youn SJ, Kim HY, Lee SW.

  Kim EH, et al.
  Dig Dis Sci. 2015 Jun;60(6):1724-32. doi: 10.1007/s10620-014-3489-4. Epub 2014 Dec 23.
  Dig Dis Sci. 2015.

  PMID: 25532503

  Clinical Trial.

• Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.

  Hamamoto N, Hashimoto T, Adachi K, Hirakawa K, Ishihara S, Inoue H, Taniura H, Niigaki M, Sato S, Kushiyama Y, Suetsugu H, Miyake T, Kinoshita Y.

  Hamamoto N, et al.
  J Gastroenterol Hepatol. 2005 Feb;20(2):281-6. doi: 10.1111/j.1440-1746.2004.03546.x.
  J Gastroenterol Hepatol. 2005.

  PMID: 15683433

  Clinical Trial.

• Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis.

  Simon TJ, Roberts WG, Berlin RG, Hayden LJ, Berman RS, Reagan JE.

  Simon TJ, et al.
  Clin Ther. 1995 Nov-Dec;17(6):1147-56. doi: 10.1016/0149-2918(95)80093-x.
  Clin Ther. 1995.

  PMID: 8750406

  Clinical Trial.

• Famotidine in gastroesophageal reflux disease (GERD).

  Wesdorp IC.

  Wesdorp IC.
  Hepatogastroenterology. 1992 Feb;39 Suppl 1:24-6.
  Hepatogastroenterology. 1992.

  PMID: 1577391

  Review.

See all similar articles

Cited by

• The impact of the coronavirus pandemic on the household waste flow during the containment period.

  Mohamed K, Amina MS, Mouaz MBE, Zihad B, Wafa R.

  Mohamed K, et al.
  Environ Anal Health Toxicol. 2021 Jun;36(2):e2021011-0. doi: 10.5620/eaht.2021011. Epub 2021 Jun 16.
  Environ Anal Health Toxicol. 2021.

  PMID: 34130376
  Free PMC article.

• Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective.

  Duru CE, Umar HIU, Duru IA, Enenebeaku UE, Ngozi-Olehi LC, Enyoh CE.

  Duru CE, et al.
  Environ Anal Health Toxicol. 2021 Jun;36(2):e2021010-0. doi: 10.5620/eaht.2021010. Epub 2021 Jun 14.
  Environ Anal Health Toxicol. 2021.

  PMID: 34130375
  Free PMC article.

• Evidence for therapeutic equivalence of lansoprazole 30mg and esomeprazole 40mg in the treatment of erosive oesophagitis.

  Howden CW, Ballard ED 2nd, Robieson W.

  Howden CW, et al.
  Clin Drug Investig. 2002;22(2):99-109. doi: 10.2165/00044011-200222020-00004.
  Clin Drug Investig. 2002.

  PMID: 23315397

• Head-to-head comparison of h3-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.

  Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Lam SK, Wong BC.

  Wang WH, et al.
  World J Gastroenterol. 2005 Jul 14;11(26):4067-77. doi: 10.3748/wjg.v11.i26.4067.
  World J Gastroenterol. 2005.

  PMID: 15996033
  Free PMC article.

• Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of “cluster GERD.”.

  Oh DS, Ohning GV, Pisegna JR.

  Oh DS, et al.
  Dig Dis Sci. 2005 May;50(5):853-7. doi: 10.1007/s10620-005-2652-3.
  Dig Dis Sci. 2005.

  PMID: 15912621
  Free PMC article.

  No abstract available.

See all “Cited by” articles

References

1. 1. Alcohol Clin Exp Res. 1990 Dec;14(6):946-50

      –

      PubMed

2. 1. Dig Dis Sci. 1982 Apr;27(4):297-302

      –

      PubMed

3. 1. Lancet. 1987 Feb 14;1(8529):349-51

      –

      PubMed

4. 1. Gut. 1987 May;28(5):519-26

      –

      PubMed

5. 1. Gut. 1990 Sep;31(9):968-72

      –

      PubMed

Publication types

MeSH terms

Substances

Cite

Format:

AMA

APA

MLA

NLM

Send To

Pepcid for Dogs | Wag!

Youtube Play

Pepcid® is the brand name form of famotidine, an antihistamine that treats stomach ulcers and other chronic gastrointestinal conditions. Although formulated for human use, Pepcid® is commonly recommended by veterinarians to treat gastrointestinal symptoms associated with excess stomach acid. Read on to learn the dosage, efficacy, ingredients, and side effects of Pepcid® for dogs.

Dosage

The dosage strength and frequency will vary depending on your dog’s symptoms, age, and weight. The standard recommended dosage is 10 mg for a 20 lb dog up to twice daily. However, before giving Pepcid® to your dog, always consult your veterinarian for advice and an official diagnosis, as some conditions may be masked by this medication and may worsen. Pepcid® works best when given on an empty stomach.

Efficacy

Famotidine is an effective stomach acid suppressant, generally. It interacts with fewer drugs than other h3 receptor antagonists and rarely causes side effects unless there are other underlying conditions.

Pepcid® may help with the following symptoms and conditions:

• Acid reflux

• Chronic vomiting

• Canine parvovirus

• Inflammatory bowel disease

• Ingestion of an ulcerating toxin

• Inflammation or erosion of the stomach lining

• Enlargement of the esophagus (megaesophagus)

Pepcid® is a short-acting medication that lasts up to 24 hours. The duration may be longer in dogs with kidney or liver disease. Pepcid® may also be recommended for dogs taking medications or diagnosed with diseases that irritate the stomach or cause excess stomach acid secretion.

Ingredients in Pepcid®

The active ingredient in Pepcid® is famotidine, an antihistamine that inhibits stomach acid secretion.

Inactive ingredients include:

• talc

• hypromellose

• red iron oxide

• carnauba wax

• titanium dioxide

• magnesium stearate

• pregelatinized starch

• hydroxypropyl cellulose

• microcrystalline cellulose

These ingredients add color, facilitate easy swallowing, help prevent caking, and increase the duration of a drug’s release into the system. If you have questions, ask your vet or pharmacist.

Side effects

Side effects associated with Pepcid® are rare, but usually mild. If you notice any of the following side effects, contact your vet immediately:

• Vomiting

• Diarrhea

• Dry skin

• Loss of appetite

Considerations

The FDA has not approved Pepcid® for veterinary use. However, many veterinarians regularly recommend this over-the-counter medication for dogs experiencing chronic gastrointestinal symptoms. If you have any concerns about its safety, consult your veterinarian.

Use Pepcid® with caution in pregnant or lactating dogs, as well as those diagnosed with kidney or liver disease.

Additionally, the symptoms of stomach ulceration are similar to those of stomach cancer. To ensure the best prognosis in either case, it’s important to seek an official diagnosis before administering any medications, including Pepcid®.

Gastrointestinal symptoms can be expensive to treat. If you suspect your dog has gastrointestinal symptoms or is at risk, start searching for pet insurance today. Brought to you by Pet Insurer, Wag! Wellness lets pet parents compare insurance plans from leading companies like PetPlan and Trupanion. Find the “pawfect” plan for your pet in just a few clicks!

Drug interactions

Pepcid® interacts with fewer drugs than other h3 antihistamines like cimetidine and ranitidine. Pepcid® may interfere with the body’s ability to absorb the following medications:

• Iron salts

• SSRIs (fluoxetine)

• Heart medications (digoxin)

• Immunosuppressants (cyclosporine)

• Antibiotics (cefuroxime, cefpodoxime)

• Other acid reflux medications (cisapride)

• Antifungal medications (fluconazole, ketoconazole, and other -azole antifungals)

If your dog is taking any of these medications, administer them at least one hour prior to giving Pepcid®. Be sure to let your vet know if your dog is taking any supplements, over-the-counter medications, or prescription drugs.

Allergic reactions and sensitivity

Allergic reactions and sensitivity to famotidine are rare. If you notice signs of an allergic reaction, contact your vet immediately. Symptoms of an allergic reaction to famotidine include:

Frequently asked questions

Which form of Pepcid® should I give to my dog?

If you’re shopping around for Pepcid®, you’ll notice there are different types. Pepcid® Original Strength in the 10 mg dosage is safe for dogs. Avoid purchasing Pepcid® Complete or Pepcid® Maximum Strength, which contain additional ingredients and stronger dosages that could upset your dog’s stomach.

Is it possible for dogs to overdose on Pepcid®?

Overdose is rare. Keep all medications out of your dog’s reach. If you notice any of the following symptoms, contact your veterinarian or the Pet Poison Helpline immediately:

• Collapse

• Lethargy

• Vomiting

• Diarrhea

• Pale gums

• Restlessness

• Difficulty breathing

• Low blood pressure

• Loss of coordination

• Irregular or rapid heartbeat

If famotidine is an antihistamine, does it treat other types of allergic reactions?

Famotidine works differently than other antihistamines used to treat skin and nasal allergies. Famotidine is an h3 blocker. Skin and nasal allergies arise when histamine binds to h2 receptors. If your dog has skin or nasal allergies, ask your vet for advice on which medication to use.

Pepcid Questions and Advice from Veterinary Professionals

How long should I give my dog ​​Pepsid?

Pepcid dosage for dogs: For both dogs and cats, the dose is one 10-milligram tablet for a 20-pound dog every 12-24 hours, says Dr. Klein. It is best to give this medicine one hour before meals.

In conclusion, these results suggest that famotidine loses its effectiveness as an acid suppressant over time when administered twice daily to dogs. Therefore, caution is advised in recommending long-term oral administration of famotidine to dogs.

Pepsid® is a short acting medicine that lasts up to 24 hours. In dogs with kidney or liver disease, the duration may be longer.

To prevent heartburn, take 1 tablet with a glass of water 15-60 minutes before eating or drinking a drink that causes heartburn. Do not take more than 2 tablets in 24 hours unless directed by a doctor. Do not use for more than 14 days in a row without consulting your doctor.

This medicine should work within 1-2 hours; however, the effects may not be noticeable and your veterinarian may need to run lab tests to evaluate if the medication is working.

Pepcid dosage for dogs: For both dogs and cats, the dose is one 10-milligram tablet for a 20-pound dog every 12-24 hours, says Dr. Klein. It is best to give this medicine one hour before meals. Check with your veterinarian to make sure the dosage is right for your pet.

Most cases are treated at home by fasting for one to two days and then following a dietary regimen of low fat, low protein meals given in small, frequent feedings.

If you suspect or know your pet has overdosed, it can be fatal, so contact your veterinarian, veterinary clinic, or the Pet Poisons Helpline at (855) 213-6680 immediately.

A common sign of acid reflux in dogs is vomiting of bile or regurgitation of undigested food shortly after consumption. 1 Bile is a yellow substance that is secreted on an empty stomach. It usually passes through the stomach into the intestines, but if the dog has acid reflux, it may come out of the mouth.

Keeping your dog on a consistent, frequent meal schedule will help relieve pressure on the gastrointestinal tract and reduce the risk of acid reflux. If your dog is prone to acid reflux, softer dog foods are a good alternative. Soft foods reduce the amount of digestive enzymes needed to digest food.

PEPCID® h3 blocker. Both Initial Strength and Maximum Strength PEPCID AC® take effect in 15-30 minutes and help control acidity all day or all night. * PEPCID COMPLETE® Dual Action combines an h3 blocker with an antacid so it starts to neutralize acid in seconds but has long lasting relief like an h3 blocker.

Adults? 20 milligrams (mg) every 6 hours. Your doctor may change your dose as needed.

Probiotics; The intestinal microbiota ensures a healthy ecology and functioning of the intestine. We know from research that good bacteria protect the intestinal mucosa, help maintain immunity, promote food digestion, and prevent the uncontrolled growth of bad bacteria and yeast (associated with reflux).

Omeprazole is a prescription drug for dogs and cats that reduces the amount of acid produced in the stomach.

Pepsid instructions, description and reviews

Pronunciation

Generic name: famotidine (fam OH ti deen)
Brand names: heartburn relief, pepsid, pepsid AC, maximum strength pepsid, pepsid RPD, Mylanta AR, leader acid reducer 9003 7

Pepsid (famotidine) histamine-2 blockers. Famotidine works by decreasing the amount of acid the stomach produces.

Pepsid is used to treat and prevent ulcers in the stomach and intestines. He also looks at conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome. Pepsid also treats gastroesophageal reflux disease (GERD) and other conditions in which acid backs up from the stomach into the esophagus, causing heartburn.

Pepsid may also be used for purposes not listed in this medication guide.

You should not use Pepcid if you are allergic to famotidine or similar drugs such as ranitidine (Zantac), cimetidine (Tagamet), or nizatidine (Axid).

Before taking Pepsid, tell your doctor if you have kidney or liver disease, a history of long QT syndrome, stomach cancer or other problems, asthma, COPD, or other breathing problems.

Slideshow Newborn baby health: 8 heads from cradle and colic to whooping cough

Pepsid can only be part of a complete treatment program that also includes changes in eating habits or lifestyle. Follow your doctor’s instructions very carefully.

Heartburn is often confused with the first symptoms of a heart attack. Seek emergency medical attention if you have chest pain or a heavy feeling, pain radiating to your arm or shoulder, nausea, sweating, and a general ill feeling.

Heartburn is often confused with the first symptoms of a heart attack. Seek emergency medical attention if you have chest pain or pressure, pain radiating to your jaw or shoulder, nausea, sweating, and a general ill feeling.

You should not use Pepcid if you are allergic to famotidine or similar medicines such as ranitidine (Zantac), cimetidine (Tagamet), or nizatidine (Axid).

Ask a doctor or pharmacist if you can use this medicine if you have other medical conditions, especially:

FDA pregnancy category B. Pepcid is not expected to harm an unborn baby. Do not use this medicine without your doctor’s advice if you are pregnant.

See also: Pregnancy and Breastfeeding Warnings (for more information)

Famotidine can pass into breast milk and may harm a nursing baby. You should not breast-feed while using this medicine.

Use Pepcid exactly as directed on the label or as directed by your healthcare professional. Do not use in larger or smaller amounts or for longer than recommended.

Measure Pepcid Oral Suspension using the measuring spoon or medicine cup. If you do not have a dose measuring device, ask your pharmacist for one.

Although most ulcers heal within 4 weeks of treatment with Pepsid, it may take up to 8 weeks of use of this medicine before the ulcer heals. For best results, continue to use the product as directed. Talk to your doctor if your symptoms have not improved after 6 weeks of treatment.

Pepsid can only be part of a complete treatment program that also includes changes in eating habits or lifestyle. Follow your doctor’s instructions very carefully.

Store at room temperature away from moisture, heat and light. Do not allow liquid medicine to freeze.

Throw away any unused oral suspension that is older than 30 days.

See also: Dosing Information (more details)

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up for a missed dose.

Read also about Creatine creatine.

Seek emergency medical attention or call the Poison Help Line at 1-800-222-1222.

Avoid alcohol. This may increase the risk of damage to your stomach.

Avoid taking cimetidine (Tagamet), ranitidine (Zantac), or nizatidine (Axid) while you are taking Pepsid unless your doctor has told you to.

This drug may impair your thinking or reactions. Be careful if you drive or do anything that requires your attention.

Read also about Elokon.

Get emergency medical help if you have any of these signs of an allergic reaction to Pepsid: hives; Labored breathing; Swelling of the face, lips, tongue, or throat.

Stop using Pepcid and call your doctor at once if you have:

• Fast or pounding heartbeat with severe dizziness; or

• Unexplained muscle pain, tenderness, or weakness, especially if you also have a fever, unusual tiredness, and dark-colored urine.

Common side effects of Pepsid may include:

• Headache;

• dizziness; or

• Constipation or diarrhea.